The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report ...

A phase 1/2 open-label, multicenter, first-in-human study of the safety, tolerability, pharmacokinetics, and antitumor activity of BH-30643 in adult subjects with locally advanced or metastatic NSCLC ...

Dr. Jani highlighted the EMPIRE-1 trial, which evaluated the role of 18F-fluciclovine PET in guiding post-prostatectomy radiotherapy. The study demonstrated an improvement in 3-year freedom from ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Open-label, single-arm, single-center phase 1b/2 clinical study of fruquintinib combined with trastuzumab and XELOX in the first-line treatment of advanced HER2-positive metastatic gastric or ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently completed a Phase 1 clinical study ...

A common nasal spray may lower the risk of getting Covid-19, a new study shows. Dr. Leana Wen discusses what this all means as coronavirus cases rise.

For nearly two decades, efforts have been underway to develop biologically active immunotherapies in which the patient's own immune system is mobilized to recognize and destroy tumor cells - so-called ...

Researchers have found in a randomized controlled clinical trial that submucosal infiltration of injectable platelet-rich ...

At 62, Phyllis Jones felt trapped in darkness. She was traumatized by her mother’s recent death, ongoing pandemic stress and an increasingly toxic work environment. A sudden panic attack led to a ...